Royal Bank Of Canada Akero Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 23,098 shares of AKRO stock, worth $573,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,098
Previous 22,876
0.97%
Holding current value
$573,754
Previous $536,000
23.51%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
73.8MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$196 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$176 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$147 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$139 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$130 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.15B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...